NCT03087162View on ClinicalTrials.gov

Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter Pylori

PHASE4CompletedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

December 1, 2017

Study Completion Date

December 1, 2017

Conditions

H Pylori Eradication

Interventions

DRUG

Dexlansoprazole 60 mg once daily

Once daily dose dexlansoprazole(Dexlansoprazole(60) OD) in experimental arm and Twice daily dose dexlansoprazole(Dexlansoprazole(60) 1 BID) in active arm

Trial Locations (1)

10400

Parin siriwat, Bangkok

All Listed Sponsors

lead

Ramathibodi Hospital

OTHER

NCT03087162 - Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter Pylori | Biotech Hunter | Biotech Hunter